rethinkTHC Search
Menu
Study breakdown

Field Sobriety Tests Failed to Detect Cannabis Impairment

Randomized Controlled TrialModerate evidence
The takeaway

In a controlled study of 20 adults, standard field sobriety tests showed little sensitivity to cannabis impairment, while a novel app-based test (DRUID) reliably detected impairment from both oral and vaporized cannabis.

Law enforcement, traffic safety researchers, cannabis policy legislators

Blood THC levels returned to baseline before cannabis impairment actually subsided

What the researchers found

High-dose oral and vaporized cannabis impaired cognitive and psychomotor performance, but field sobriety tests showed little sensitivity to cannabis-induced impairment. The DRUID app was the most sensitive test, detecting significant differences from placebo for both administration routes. Blood THC levels returned to baseline before impairment resolved.

Why it matters

Current roadside methods for detecting cannabis impairment are inadequate. Blood THC levels and field sobriety tests both fail to reliably identify when someone is actually impaired, creating significant public safety and legal challenges.

The numbers in context

20 participants (10 men, 10 women); 6 sessions; low doses produced subjective effects but no measurable impairment; high doses impaired performance; DRUID detected impairment at both routes; women showed more DRUID impairment at high vaporized dose; blood THC returned to baseline before impairment resolved.

How the study worked

Double-blind, placebo-controlled, six-session outpatient study with 20 infrequent cannabis users (10 men, 10 women) receiving three oral doses (0, 10, 25 mg THC brownies) and three vaporized doses (0, 5, 20 mg THC), tested with computerized tasks, DRUID app, and field sobriety tests.

What this study cannot tell us

Small sample size (20 participants); infrequent users only (tolerance effects not captured); lab setting differs from real-world driving; limited dose range; DRUID validation still early.

How to read the evidence

Small but well-designed double-blind RCT with placebo control, limited by sample size and lab setting.

When this study was published

Published in 2021.

The bigger picture

The disconnect between blood THC concentrations and actual impairment undermines per se legal limits for THC, while the failure of field sobriety tests suggests entirely new approaches are needed for roadside cannabis impairment detection.

Questions still open

  • Could the DRUID app or similar tools replace field sobriety tests for cannabis at roadside? Should per se THC blood limits be abandoned in favor of impairment-based assessments?

Common questions

Can police tell if someone is high while driving?
This study found that standard field sobriety tests showed little sensitivity to cannabis impairment. A novel app-based test (DRUID) performed significantly better, suggesting new tools are needed for roadside testing.
Does blood THC level indicate impairment?
No. In this study, blood THC concentrations returned to baseline well before actual impairment resolved, meaning someone could test "clean" on blood THC while still being impaired by cannabis.

Read the original research

Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis.

Journal of psychopharmacology (Oxford, England), 35(7), 786-803

Citation

Spindle, Tory R; Martin, Erin L; Grabenauer, Megan; Woodward, Thomas; Milburn, Michael A; Vandrey, Ryan. (2021). Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis.. Journal of psychopharmacology (Oxford, England), 35(7), 786-803. https://doi.org/10.1177/02698811211021583